Financials in USD. Standardized financial statements.
A compact view of how Dialogue Health Technologies Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Revenue? | $87.13M | $68.05M | $35.80M | $10.09M | $4.01M |
| Revenue Growth? | +28.0% | +90.1% | +254.9% | +151.4% | 0.0% |
| Cost of Revenue? | $43.79M | $39.24M | $21.41M | $4.60M | $3.05M |
| Gross Profit? | $43.34M | $28.81M | $14.39M | $5.49M | $963,392 |
| Gross Margin? | +49.7% | +42.3% | +40.2% | +54.4% | +24.0% |
| Operating Expenses? | $69.31M | $55.43M | $34.52M | $17.24M | $10.66M |
| Operating Income? | -$25.97M | -$26.62M | -$20.13M | -$11.76M | -$9.69M |
| EBITDA? | -$21.31M | -$249.21M | -$17.32M | -$10.93M | -$9.56M |
| Income Before Tax | -$26.42M | -$251.67M | -$20.46M | -$12.04M | -$10.08M |
| Income Tax Expense | -$467,000 | -$322,232 | -$229,241 | $0 | -$2,815 |
| Net Income? | -$25.95M | -$251.35M | -$20.23M | -$12.04M | -$10.08M |
| EPS? | $-0.39 | $-4.48 | $-0.31 | $-0.19 | $-0.16 |
| Diluted EPS? | $-0.39 | $-4.48 | $-0.31 | $-0.19 | $-0.16 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality